May. 28, 2015News & Opinions
Under a ruling by a US court of appeals upholding a preliminary injunction dating from December 2014, Ireland-headquartered former US drugmaker Actavis will have to continue selling its Namenda IR tablets for treatment of moderate to ...
May. 15, 2015News & Opinions
India-based generics producer Dr Reddy's Laboratories is pleased with its performance in fiscal 2015 (March 31) achieved despite currency volatility in some emerging market geographies.
May. 07, 2015Topics
A wind of change is in the air when it comes to logistics in the pharmaceutical industry. Although most companies are still quite optimistic with regard to the current business climate, there seems to be a rising awareness of the important ...
Apr. 30, 2015News & Opinions
Still being pursued by Israeli generics giant Teva, Netherlands-based drugmaker Mylan has increased its offer to acquire the issued and to-be-issued shares of smaller generics producer Perrigo.
Apr. 28, 2015News & Opinions
In its first reaction to the hostile takeover bid by Israeli generics giant Teva, the board of Dutch-based drugmaker Mylan has unanimously rejected the more than $40 billion offer.
Apr. 24, 2015News & Opinions
US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva.
Apr. 23, 2015News & Opinions
In a pre-negotiated share sale agreed a year ago, Japan's Daiichi Sankyo has unloaded its entire 8.9% stake in India's mammoth generics producer Sun Pharmaceutical Industries, raising 200 billion rupees ($3.2 billion).
Mar. 26, 2015Topics
The pharmaceutical industry is confronting a variety of new and complex challenges in the face of globalization and changing market dynamics. The past decade has witnessed a decline in the discovery, approval and marketing of new chemical ...
Mar. 16, 2015News & Opinions
Dublin, Ireland-based Endo International has made a takeover bid for US drugmaker Salix Pharmaceuticals in an effort to thwart Valeant Pharmaceuticals International's $10 billion takeover offer.
Jan. 21, 2015News & Opinions
CPhI Worldwide has announced the launch of a new advisory board, consisting of the following industry experts who provide a wide expertise portfolio:
The latest information directly via newsletter.